Complementary medicine under scrutiny

The establishment of a new research centre for complementary medicine at Harvard Medical School signals a growing interest in subjecting complementary therapies to scientific scrutiny.

Written byTudor Toma
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LONDON Harvard Medical School is to create a new research centre to evaluate rigorously complementary and integrative medical treatments. It will be funded by a $10 million grant from the Bernard Osher Foundation and headed by associate professor David Eisenberg. Like the National Center for Complementary and Alternative Medicine at the NIH and the Osher Center for Integrative Medicine at UCSF, both established within the past three years, the new centre signals a growing interest in subjecting complementary therapies to scientific scrutiny.

Eisenberg and colleagues have reported (JAMA 1998, 280:1569-1575) that in the US in 1997, the estimated total number of visits to alternative medicine practitioners exceeded the estimated total number of visits to all primary care physicians. In addition, they estimated a total of $27 billion out-of-pocket expenditures relating to alternative therapies during 1997, which was comparable to the projected out-of-pocket expenditures for all US physician-rendered services in that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA